國立虎尾科技大學 |

Pharmaceutical formulations for older patients

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Pharmaceutical formulations for older patients/ edited by Mine Orlu, Fang Liu.
其他作者:	Liu, Fang.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	xiii, 288 p. :illustrations (chiefly color), digital ; : 24 cm.;
Contained By:	Springer Nature eBook
標題:	Biomedical Research. -
電子資源:	https://doi.org/10.1007/978-3-031-35811-1
ISBN:	9783031358111

Pharmaceutical formulations for older patients
Pharmaceutical formulations for older patients[electronic resource] /edited by Mine Orlu, Fang Liu. - Cham :Springer International Publishing :2023. - xiii, 288 p. :illustrations (chiefly color), digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v. 512210-738X ;. - AAPS advances in the pharmaceutical sciences series ;3..

Part 1: Patient-Centric Considerations.-Medicine Optimisation in Older -- Acceptability of drug formulations in older patients and effect on patient adherence -- Geriatric biopharmaceutics -- Excipient safety in older adults -- Part 2: Pharmaceutical Formulations Development for older Patients -- Oral and oromucosal formulation development and in vitro characterisation - patient-centric approaches for older adults -- Pulmonary drug delivery systems for older people -- Transdermal drug delivery systems for older patients -- Part 3 :Advanced Drug Delivery Systems for Older Patients -- Advanced oral drug delivery systems for older patients -- The ageing microbiome, pharmaceutical considerations and therapeutic opportunities -- Application of 3D printing in geriatric medicines, -- Application of electrospraying and advanced fabrication methods in geriatric medicines -- Vaccine development for older patients.

Pharmaceutical formulation design affects patient acceptability/adherence and pharmacokinetics of the drug. This is particularly important for older patients because of the physiological changes due to ageing and clinical/social circumstances related to medicine taking. This book provides a comprehensive review in the design of formulations to meet the needs of older patients. An overview of the key clinical, social and pharmaceutical factors affecting medication optimization, safety and acceptability in older adults is included, followed by patient-centric considerations including regulatory requirements, dosage form design and human factor studies. Advanced pharmaceutical technologies are discussed for their potential use in older adults such as 3D printing, long-acting oral formulations and novel vaccine technologies. The unique focus of the book will be of interest to pharmaceutical scientists in both industry and academia in searching for better formulations for older patients.

ISBN: 9783031358111

Standard No.: 10.1007/978-3-031-35811-1doiSubjects--Topical Terms:

643481
Biomedical Research.

LC Class. No.: RM301.5

Dewey Class. No.: 615.70846

Pharmaceutical formulations for older patients
LDR:03011nam a2200337 a 4500 001 1119493
003 DE-He213
005 20231110161735.0
006 m d
007 cr nn 008maaau
008 240612s2023 sz s 0 eng d
020 $a 9783031358111 $q (electronic bk.)
020 $a 9783031358104 $q (paper)
024 7 $a 10.1007/978-3-031-35811-1 $2 doi
035 $a 978-3-031-35811-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.5
072 7 $a TCB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 615.70846 $2 23
090 $a RM301.5 $b .P536 2023
245 0 0 $a Pharmaceutical formulations for older patients $h [electronic resource] / $c edited by Mine Orlu, Fang Liu.
260 $a Cham : $c 2023. $b Springer International Publishing : $b Imprint: Springer,
300 $a xiii, 288 p. : $b illustrations (chiefly color), digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-738X ; $v v. 51
505 0 $a Part 1: Patient-Centric Considerations.-Medicine Optimisation in Older -- Acceptability of drug formulations in older patients and effect on patient adherence -- Geriatric biopharmaceutics -- Excipient safety in older adults -- Part 2: Pharmaceutical Formulations Development for older Patients -- Oral and oromucosal formulation development and in vitro characterisation - patient-centric approaches for older adults -- Pulmonary drug delivery systems for older people -- Transdermal drug delivery systems for older patients -- Part 3 :Advanced Drug Delivery Systems for Older Patients -- Advanced oral drug delivery systems for older patients -- The ageing microbiome, pharmaceutical considerations and therapeutic opportunities -- Application of 3D printing in geriatric medicines, -- Application of electrospraying and advanced fabrication methods in geriatric medicines -- Vaccine development for older patients.
520 $a Pharmaceutical formulation design affects patient acceptability/adherence and pharmacokinetics of the drug. This is particularly important for older patients because of the physiological changes due to ageing and clinical/social circumstances related to medicine taking. This book provides a comprehensive review in the design of formulations to meet the needs of older patients. An overview of the key clinical, social and pharmaceutical factors affecting medication optimization, safety and acceptability in older adults is included, followed by patient-centric considerations including regulatory requirements, dosage form design and human factor studies. Advanced pharmaceutical technologies are discussed for their potential use in older adults such as 3D printing, long-acting oral formulations and novel vaccine technologies. The unique focus of the book will be of interest to pharmaceutical scientists in both industry and academia in searching for better formulations for older patients.
650 2 4 $a Biomedical Research. $3 643481
650 2 4 $a Pharmacology. $3 583819
650 2 4 $a Pharmaceutics. $3 1366841
650 1 4 $a Drug Delivery. $3 1366630
650 0 $a Pharmacokinetics $x Age factors. $3 1434273
700 1 $a Liu, Fang. $e author. $3 1274132
700 1 $a Orlu, Mine. $3 1434272
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 889162
856 4 0 $u https://doi.org/10.1007/978-3-031-35811-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)